Pharmacological Management of Delirium

Completed · Not applicable

Conditions studied: Delirium, Cognitive Impairment

In brief

The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration as well as length of stay and mortality compared to usual care.

Key facts

Study ID

NCT00842608

Run by

Indiana University

People needed

551

Starts

2009-02-01

Expected to finish

2015-07-01

Last updated by the study team

2018-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Hospitalized on an ICU ward
• Delirium based on the RASS and the CAM-ICU assessments at any day during ICU stay
• English speaking

You may not qualify if…

• Admitted directly to a regular non-ICU ward
• Previously enrolled in the study
• Not eligible for delirium assessment as determined by RASS scores
• Prior history of severe mental illness
• Alcohol-related delirium
• Pregnant or nursing
• Have had an aphasic stroke

Where it is running

• Eskenazi Hospital — Indianapolis, Indiana, United States
• Methodist Hospital — Indianapolis, Indiana, United States
• University Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.